Drug:
Reaction: ASTHMA
20250101 - 20251231
No. 201 - 300
No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
201 | 25111387 |
JP |
||
Asthma, |
||||
PROPRANOLOL HYDROCHLORIDE, |
||||
202 | 25111424 |
CA |
||
Asthma, Chest pain, Cough, Dyspnoea, Malaise, Nasal oedema, Oedema, Pain, Pneumonia, Respiratory tract infection, Vomiting, Wheezing, Drug hypersensitivity, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, AMLODIPINE BESYLATE, AMLODIPINE BESYLATE, AMLODIPINE BESYLATE, CALCIUM, CALCIUM, CALCIUM CARBONATE, CALCIUM CARBONATE, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, CIPROFLOXACIN HYDROCHLORIDE, CLONAZEPAM, CLONAZEPAM, ERGOCALCIFEROL, ERGOCALCIFEROL, FOLIC ACID, HYDROMORPHONE HYDROCHLORIDE, MONTELUKAST, MONTELUKAST, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, PREDNISONE, PREDNISONE, RISEDRONATE SODIUM, RISEDRONATE SODIUM, RITUXIMAB, RITUXIMAB, ROPIVACAINE HYDROCHLORIDE, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, THEOPHYLLINE, THEOPHYLLINE, TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE, |
||||
203 | 25111457 |
CA |
56 | 1 |
Adenoidectomy, Asthma, Atelectasis, Blood immunoglobulin E increased, Bronchial secretion retention, Bronchial wall thickening, Bronchiolitis, Chronic obstructive pulmonary disease, Diaphragmatic disorder, Emphysema, Eosinophil count increased, Full blood count abnormal, Gastrooesophageal reflux disease, Hospitalisation, Idiopathic interstitial pneumonia, Increased appetite, Loss of personal independence in daily activities, Lung diffusion disorder, Mediastinal mass, Migraine, Mycobacterial infection, Nasal congestion, Nasal oedema, Nasal polyps, Obstructive airways disorder, Productive cough, Pulmonary eosinophilia, Pulmonary granuloma, Pulmonary mass, Respiratory disorder, Sleep disorder due to a general medical condition, Sputum discoloured, Therapeutic product effect incomplete, Tonsillectomy, Umbilical hernia, Vasculitis, Weight increased, Wheezing, Abdominal distension, Dyspnoea, Dyspnoea exertional, Asthenia, Chest discomfort, Dry mouth, Headache, Palpitations, |
||||
BUDESONIDE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, PREDNISONE, ALBUTEROL SULFATE, TIOTROPIUM BROMIDE, NICOTINE POLACRILEX, NICOTINE, NICOTINE POLACRILEX MINI, NICOTINE POLARILEX, |
||||
204 | 25111467 |
CA |
60 | 2 |
Full blood count abnormal, Secondary immunodeficiency, Drug intolerance, Nicotine dependence, Obstructive airways disorder, Asthma, Sputum purulent, Myalgia, Wheezing, Cough, Fatigue, Abdominal distension, Hypersensitivity, Abdominal pain, Constipation, Therapeutic product effect incomplete, |
||||
CALCIUM CARBONATE, CALCIUM CARBONATE, CALCIUM CARBONATE, CALCIUM CARBONATE, CALCIUM CARBONATE, CALCIUM CARBONATE, CALCIUM CARBONATE, CALCIUM CARBONATE, CICLESONIDE, CICLESONIDE, CICLESONIDE, CICLESONIDE, CICLESONIDE, CICLESONIDE, CICLESONIDE, CICLESONIDE, CICLESONIDE, CICLESONIDE, LORAZEPAM, LORAZEPAM, LORAZEPAM, LORAZEPAM, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, RABEPRAZOLE SODIUM, RABEPRAZOLE, RABEPRAZOLE SODIUM, RABEPRAZOLE, RABEPRAZOLE SODIUM, RABEPRAZOLE, ERGOCALCIFEROL, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, ERGOCALCIFEROL, ERGOCALCIFEROL, ERGOCALCIFEROL, ERGOCALCIFEROL, ERGOCALCIFEROL, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, BUPROPION HYDROBROMIDE, BUPROPION HYDROBROMIDE, NICOTINE POLACRILEX, NICOTINE, NICOTINE POLACRILEX MINI, NICOTINE POLARILEX, LORAZEPAM, LORAZEPAM, LORAZEPAM, BUPROPION HYDROCHLORIDE, BUPROPION, BUPROPION HYDROCHLORIDE, BUPROPION, BUPROPION HYDROCHLORIDE, BUPROPION, BUPROPION HYDROCHLORIDE, BUPROPION, BUPROPION HYDROBROMIDE, BUPROPION HYDROBROMIDE, BUPROPION HYDROBROMIDE, CEFTRIAXONE, CEFTRIAXONE SODIUM, CEFTRIAXONE, CEFTRIAXONE SODIUM, CEFTRIAXONE, CEFTRIAXONE SODIUM, CEFUROXIME AXETIL, CEFUROXIME AXETIL, CEFUROXIME AXETIL, CEFUROXIME AXETIL, CICLESONIDE, CICLESONIDE, CICLESONIDE, CICLESONIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN, MOXIFLOXACIN HYDROCHLORIDE, RABEPRAZOLE SODIUM, RABEPRAZOLE, RABEPRAZOLE SODIUM, RABEPRAZOLE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, RABEPRAZOLE, RABEPRAZOLE, ALBUTEROL SULFATE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, NICOTINE POLACRILEX, NICOTINE, NICOTINE POLACRILEX MINI, NICOTINE POLARILEX, |
||||
205 | 25111833 |
US |
56 | 2 |
Pneumonia, Asthma, Eye infection, Condition aggravated, Swelling of eyelid, Eyelid pain, Abnormal sensation in eye, Dry eye, Chest pain, Dyspnoea, Inflammation, |
||||
TOFACITINIB, |
||||
206 | 25111844 |
CA |
65 | 2 |
Asthma, Chest pain, Cough, Drug hypersensitivity, Dyspnoea, Malaise, Pneumonia, Respiratory tract infection, Vomiting, Wheezing, Oedema, Pain, |
||||
AMLODIPINE, CALCIUM CARBONATE, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, CLONAZEPAM, FOLIC ACID, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN, PREDNISONE, RISEDRONATE SODIUM, ROSUVASTATIN, THEOPHYLLINE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, ERGOCALCIFEROL, OMALIZUMAB, RITUXIMAB, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, MONTELUKAST SODIUM, |
||||
207 | 25112163 |
US |
||
Cardiac failure, Pulmonary arterial hypertension, Impaired gastric emptying, Catheterisation cardiac, Taste disorder, Dyspnoea, Drug effect less than expected, Fall, Tendon injury, Wound complication, Concussion, Dizziness, Ear discomfort, Headache, Swelling, Dyspnoea, Asthma, Brain fog, Abdominal pain upper, Depression, Fear of falling, Cough, Urinary incontinence, Anal incontinence, |
||||
BENRALIZUMAB, |
||||
208 | 25112666 |
CA |
73 | 2 |
Arthritis, Asthma, Depression, Dyspnoea, Glaucoma, Sleep apnoea syndrome, |
||||
CICLESONIDE, CICLESONIDE, AMLODIPINE BESYLATE, AMLODIPINE BESYLATE, GABAPENTIN, GABAPENTIN, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, PREDNISONE, ALBUTEROL SULFATE, ALBUTEROL, GLYCOPYRROLATE, GLYCOPYRROLATE, GLYCOPYRROLATE, TELMISARTAN, ALBUTEROL SULFATE, ALBUTEROL, AMLODIPINE BESYLATE, GABAPENTIN, PREDNISONE, TELMISARTAN, GLYCOPYRROLATE, CYANOCOBALAMIN, CYANOCOBALAMIN, GLYCOPYRROLATE, |
||||
209 | 25112794 |
CA |
53 | 1 |
Dyspnoea, Cough, Hyperhidrosis, Pyrexia, Chills, Viral infection, Wheezing, Asthma, Respiratory tract infection, Off label use, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, AZATHIOPRINE, |
||||
210 | 25113028 |
US |
||
Anaphylactic reaction, Product dose omission issue, Asthma, Food allergy, Hypersensitivity, Manufacturing materials issue, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
211 | 25113479 |
CA |
36 | 2 |
Diabetes mellitus, Asthma, Malaise, Metabolic disorder, Sneezing, Urticaria, Body mass index increased, Cough, Drug ineffective, Dyspnoea, Food allergy, Glucose tolerance impaired, Injection site bruising, Diarrhoea, Insomnia, Weight increased, Lung disorder, Wheezing, Fatigue, Nausea, Lethargy, Weight decreased, COVID-19, Skin sensitisation, Inappropriate schedule of product administration, Vomiting, Middle insomnia, Blood pressure increased, Sinus disorder, Product dose omission issue, |
||||
METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE, ALBUTEROL SULFATE, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, FLUTICASONE PROPIONATE, TRIPROLIDINE HCL, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE, AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE, ESCITALOPRAM OXALATE, ESCITALOPRAM, MEDROXYPROGESTERONE ACETATE, |
||||
212 | 25113481 |
FR |
46 | 1 |
Asthma, |
||||
EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE, |
||||
213 | 25113589 |
US |
63 | 1 |
Myocardial infarction, Asthma, Dyspnoea, Fatigue, Sneezing, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
214 | 25113853 |
CA |
60 | |
Asthma, Blood lactic acid increased, Blood potassium decreased, Breath sounds abnormal, Chest X-ray abnormal, Chest discomfort, Cough, Dyspnoea, Ear pruritus, Eosinophilia, Eye pruritus, Full blood count abnormal, Lacrimation increased, Lung disorder, Nasal congestion, Nasal polyps, Platelet count increased, Pulmonary function test abnormal, Rhinitis allergic, Rhinorrhoea, Sneezing, Upper-airway cough syndrome, Urticaria, Vasculitis, Wheezing, |
||||
AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, BUDESONIDE, CEFTRIAXONE, CEFTRIAXONE SODIUM, MEPOLIZUMAB, OMALIZUMAB, PREDNISONE, ALBUTEROL SULFATE, ALBUTEROL, MONTELUKAST SODIUM, OSELTAMIVIR PHOSPHATE, |
||||
215 | 25114215 |
US |
1 | |
Impaired quality of life, Asthma, |
||||
DUPILUMAB, DUPILUMAB, |
||||
216 | 25114254 |
US |
1 | |
Asthma, Impaired quality of life, |
||||
DUPILUMAB, |
||||
217 | 25114308 |
US |
58 | 2 |
Asthma, Sleep disorder due to a general medical condition, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
218 | 25114333 |
US |
2 | |
Influenza, Nasopharyngitis, Asthma, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
219 | 25114401 |
US |
55 | 2 |
Impaired quality of life, Asthma, Dyspnoea, Respiratory tract infection, |
||||
DUPILUMAB, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, BENZONATATE, CROMOLYN SODIUM, DULOXETINE HYDROCHLORIDE, DULOXETINE, DULOXETINE HYDROCHLORIDE, DULOXETINE, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, FAMOTIDINE, BENRALIZUMAB, FLUCONAZOLE, FLUCONAZOLE, GABAPENTIN, GABAPENTIN, HYDRALAZINE HYDROCHLORIDE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LACTULOSE, LORAZEPAM, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METHOCARBAMOL, METHOCARBAMOL TABLETS, MOMETASONE, NAPROXEN, NAPROXEN SODIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OXYBUTYNIN, PANTOPRAZOLE, PREDNISONE, PREDNISONE, LIRAGLUTIDE, MONTELUKAST SODIUM, SUCRALFATE, SUCRALFATE ORAL SUSPENSION, SUCRALFATE ORAL, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, ALBUTEROL SULFATE, SERTRALINE HYDROCHLORIDE, |
||||
220 | 25114500 |
US |
64 | 2 |
Asthma, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
221 | 25114625 |
US |
2 | |
Asthma, |
||||
DUPILUMAB, |
||||
222 | 25115085 |
CA |
64 | |
Asthma, Full blood count abnormal, Cardiac failure congestive, Crepitations, Dyspnoea, Emotional distress, Hypersensitivity pneumonitis, Rhonchi, Weight increased, Drug ineffective, Loss of personal independence in daily activities, |
||||
ACLIDINIUM BROMIDE, ACLIDINIUM BROMIDE, MEPOLIZUMAB, PREDNISONE, PREDNISONE, PREDNISONE, MONTELUKAST SODIUM, SPIRONOLACTONE, ALBUTEROL SULFATE, |
||||
223 | 25109185 |
US |
2 | |
Asthma, |
||||
DUPILUMAB, |
||||
224 | 25109188 |
US |
||
Asthma, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
225 | 25109208 |
US |
2 | |
Asthma, |
||||
DUPILUMAB, |
||||
226 | 25109213 |
CA |
51 | 2 |
Asthma, Head injury, Illness, Respiratory syncytial virus infection, Influenza, Infection, Pneumonia, Dizziness, Dyspnoea, Fall, Inappropriate schedule of product administration, |
||||
GABAPENTIN, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MODAFINIL, MONTELUKAST, OXYGEN, 0XYGEN, PREDNISONE, PREDNISONE, ALBUTEROL SULFATE, ALBUTEROL, |
||||
227 | 25109337 |
US |
45 | 2 |
Asthma, Product dose omission in error, Inappropriate schedule of product administration, |
||||
DUPILUMAB, DUPILUMAB, ALBUTEROL SULFATE, ALBUTEROL SULFATE, |
||||
228 | 25109436 |
US |
64 | 2 |
Cough, Asthma, |
||||
DUPILUMAB, |
||||
229 | 25109548 |
US |
55 | 2 |
Influenza, Asthma, |
||||
DUPILUMAB, DUPILUMAB, |
||||
230 | 25107757 |
US |
31 | 2 |
Asthma, Skin fissures, Skin haemorrhage, Eczema, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
231 | 25107790 |
US |
2 | |
Depressed mood, Decreased interest, Asthma, Dyspnoea, |
||||
DUPILUMAB, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, ARIPIPRAZOLE, ALPRAZOLAM, OIL, BIOTIN, HAIR, CALCIUM, CYCLOBENZAPRINE, FUROSEMIDE, LEVOTHYROXINE, MONTELUKAST, SEMAGLUTIDE, PREDNISONE, SERTRALINE HYDROCHLORIDE, URSODIOL, URSOSIOL, |
||||
232 | 25107817 |
US |
50 | 2 |
Infection, Asthma, |
||||
DUPILUMAB, |
||||
233 | 25107836 |
US |
46 | 2 |
Stress, Asthma, |
||||
DUPILUMAB, |
||||
234 | 25107842 |
US |
12 | 2 |
Asthma, |
||||
DUPILUMAB, |
||||
235 | 25107852 |
US |
57 | 2 |
Headache, Asthma, |
||||
DUPILUMAB, DUPILUMAB, |
||||
236 | 25107860 |
US |
45 | 2 |
Asthma, Drug ineffective, |
||||
DUPILUMAB, |
||||
237 | 25107906 |
US |
38 | 2 |
Asthma, |
||||
DUPILUMAB, |
||||
238 | 25107912 |
US |
36 | 1 |
Asthma, |
||||
DUPILUMAB, |
||||
239 | 25107959 |
US |
38 | 2 |
Asthma, |
||||
DUPILUMAB, |
||||
240 | 25107963 |
US |
10 | 1 |
Asthma, Drug ineffective, Impaired quality of life, |
||||
DUPILUMAB, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, MONTELUKAST, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISONE, SODIUM FLUORIDE, SODIUM FLUORIDE AND POTASSIUM NITRATE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
241 | 25107998 |
US |
10 | 2 |
Asthma, |
||||
DUPILUMAB, |
||||
242 | 25108001 |
US |
38 | 2 |
Dyspnoea exertional, Respiratory tract infection, Influenza, Asthma, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
243 | 25108021 |
US |
24 | 2 |
Eczema, Asthma, Hypersensitivity, |
||||
DUPILUMAB, |
||||
244 | 25108023 |
US |
62 | 2 |
Nasopharyngitis, Asthma, |
||||
DUPILUMAB, |
||||
245 | 25108046 |
US |
63 | 2 |
Asthma, |
||||
DUPILUMAB, |
||||
246 | 25108062 |
US |
63 | 2 |
Quality of life decreased, Asthma, |
||||
DUPILUMAB, |
||||
247 | 25108065 |
US |
28 | 1 |
Impaired quality of life, Asthma, |
||||
DUPILUMAB, ALBUTEROL SULFATE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, |
||||
248 | 25108097 |
US |
71 | 2 |
Nasopharyngitis, Asthma, |
||||
DUPILUMAB, |
||||
249 | 25108173 |
US |
53 | 2 |
Asthma, |
||||
DUPILUMAB, |
||||
250 | 25108270 |
US |
3 | 2 |
Sleep disorder, Asthma, |
||||
DUPILUMAB, |
||||
251 | 25108275 |
CA |
44 | 2 |
X-ray abnormal, Diarrhoea, Hepatic enzyme increased, Abdominal discomfort, Abdominal pain, Abdominal pain upper, Adjustment disorder with depressed mood, Alopecia, Amnesia, Anti-cyclic citrullinated peptide antibody positive, Anxiety, Arthralgia, Arthritis, Arthropathy, Asthenia, Asthma, Autoimmune disorder, Blister, Blood cholesterol increased, Bone erosion, Breast cancer stage III, Bursitis, C-reactive protein abnormal, Chest pain, Colitis ulcerative, Condition aggravated, Contusion, Crohn^s disease, Delirium, Decreased appetite, Depression, Discomfort, Dislocation of vertebra, Dizziness, Drug hypersensitivity, Dry mouth, Duodenal ulcer perforation, Dyspepsia, Dyspnoea, Ear infection, Exostosis, Facet joint syndrome, Fatigue, Feeling hot, Fibromyalgia, Folliculitis, Foot deformity, Frequent bowel movements, Gait disturbance, Gastrointestinal disorder, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, SECUKINUMAB, SECUKINUMAB, LEFLUNOMIDE, |
||||
252 | 25108383 |
US |
4 | 1 |
Rebound eczema, Rebound effect, Asthma, Intentional dose omission, |
||||
DUPILUMAB, |
||||
253 | 25108709 |
US |
2 | |
Asthma, |
||||
DUPILUMAB, |
||||
254 | 25108783 |
AT |
41 | 1 |
Intervertebral disc protrusion, Asthma, |
||||
ADALIMUMAB, ADALIMUMAB, |
||||
255 | 25108853 |
US |
37 | 2 |
Infection, Asthma, |
||||
DUPILUMAB, |
||||
256 | 25108901 |
US |
63 | 2 |
Impaired quality of life, Asthma, |
||||
DUPILUMAB, BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, LEVOTHYROXINE, MODAFINIL, MONTELUKAST, OLANZAPINE, OLANZAPINE, ZONISAMIDE, |
||||
257 | 25109043 |
US |
1 | |
Asthma, Rebound effect, Product dose omission issue, Nasopharyngitis, |
||||
DUPILUMAB, |
||||
258 | 25109112 |
US |
55 | 1 |
Asthma, |
||||
DUPILUMAB, |
||||
259 | 25102500 |
US |
2 | |
Asthma, Chest discomfort, |
||||
OMALIZUMAB, OMALIZUMAB, |
||||
260 | 25102690 |
CA |
61 | |
Hypertension, Asthma, Cataract, Gout, Pneumonia, Red cell distribution width increased, Sinus polyp, Single functional kidney, Sinusitis, Muscle spasms, Dry skin, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, MOMETASONE FUROATE, ALBUTEROL SULFATE, MONTELUKAST SODIUM, ALLOPURINOL, AMLODIPINE BESYLATE, RANITIDINE, MEPOLIZUMAB, |
||||
261 | 25102985 |
US |
||
Asthma, Drug dose omission by device, Device delivery system issue, |
||||
LEVALBUTEROL TARTRATE, |
||||
262 | 25103100 |
CA |
63 | 2 |
Arthritis infective, Back pain, Blood pressure systolic increased, Bronchitis, Chest discomfort, Chest pain, Cystitis, Forced expiratory volume decreased, Gait inability, Gastrooesophageal reflux disease, Hypoaesthesia, Ill-defined disorder, Lung hyperinflation, Middle insomnia, Muscle tightness, Musculoskeletal discomfort, Nasopharyngitis, Obstructive airways disorder, Postoperative wound complication, Respiratory gas exchange disorder, Rotator cuff syndrome, Skin infection, Thermal burn, Weight decreased, Wound secretion, Pain, Paraesthesia, Upper respiratory tract infection, Arthralgia, Asthma, Dizziness, Viral pharyngitis, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, MONTELUKAST SODIUM, MONTELUKAST SODIUM, |
||||
263 | 25103214 |
CA |
65 | 2 |
Asthma, Drug hypersensitivity, Wheezing, Pneumonia, Vomiting, Oedema, Dyspnoea, |
||||
AMLODIPINE, CALCIUM CARBONATE, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, CLONAZEPAM, FOLIC ACID, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN, PREDNISONE, RISEDRONATE SODIUM, ROSUVASTATIN, THEOPHYLLINE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, ERGOCALCIFEROL, OMALIZUMAB, RITUXIMAB, ROPIVACAINE HYDROCHLORIDE, MONTELUKAST SODIUM, |
||||
264 | 25103681 |
GB |
45 | 1 |
Asthma, |
||||
IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
265 | 25103719 |
CA |
44 | 2 |
Arthralgia, Arthritis, Arthropathy, Asthenia, Asthma, Blood cholesterol increased, Bone erosion, Breast cancer stage III, Bursitis, C-reactive protein abnormal, Chest pain, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, FLUOROMETHOLONE, RITUXIMAB, RITUXIMAB, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, LEFLUNOMIDE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, PREGABALIN, SECUKINUMAB, SECUKINUMAB, MAGNESIUM, LANSOPRAZOLE, ERGOCALCIFEROL, ALBUTEROL SULFATE, MORPHINE, CALCIUM, VITAMIN C, LORAZEPAM, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, AZATHIOPRINE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, ALBUTEROL SULFATE, ALBUTEROL, RAMIPRIL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, PREDNISONE, PREDNISONE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LORAZEPAM, CAFFEINE, CAFFEINE CITRATE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, IBUPROFEN TABLET COATED, CALCIUM CARBONATE, DOXYCYCLINE, DOXYCYCLINE HYCLATE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, APREPITANT, FOSAPREPITANT DIMEGLUMINE, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ERYTHROMYCIN, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, FOSAPREPITANT, FOSAPREPITANT DIMEGLUMINE, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, HYALURONIDASE, INFLIXIMAB, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, LISINOPRIL, MELOXICAM, MESALAMINE, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, APREMILAST, APREMILAST, APREMILAST, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, SULFASALAZINE, SULFASALAZINE, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOFACITINIB, LISINOPRIL, SECUKINUMAB, |
||||
266 | 25103855 |
CA |
||
Asthma, Inappropriate schedule of product administration, |
||||
MEPOLIZUMAB, ALBUTEROL SULFATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, |
||||
267 | 25103862 |
GB |
73 | 2 |
Asthma, |
||||
268 | 25103891 |
|||
Asthma, |
||||
BENRALIZUMAB, |
||||
269 | 25103946 |
US |
2 | |
Asthma, Off label use, |
||||
OMALIZUMAB, |
||||
270 | 25104070 |
CA |
64 | 2 |
Abdominal pain upper, Arthralgia, Asthma, Autoimmune disorder, Back pain, Biliary colic, Blood pressure systolic increased, Chest pain, Cholecystitis, Confusional state, Cough, Dry mouth, Dyspnoea, Exposure to allergen, Fatigue, Feeling abnormal, Feeling cold, Feeling of body temperature change, Forced expiratory volume decreased, Gait disturbance, Gastroenteritis viral, Gingival recession, Headache, Heart rate increased, Hyperhidrosis, Illness, Inappropriate schedule of product administration, Inflammation, Influenza, Lumbar vertebral fracture, Middle insomnia, Migraine, Muscle spasms, Musculoskeletal stiffness, Nasopharyngitis, Nausea, Obstructive airways disorder, Oral disorder, Oropharyngeal pain, Pain, Pancreatitis, Pneumonia, Post procedural complication, Pyrexia, Therapeutic response decreased, Type 2 diabetes mellitus, Vomiting, Weight decreased, Weight increased, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, MORPHINE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, BUDESONIDE, BUDESONIDE, CANDESARTAN, CANDESARTAN, CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE, CLONIDINE, CLONIDINE, CLOZAPINE, CYCLOBENZAPRINE, CYCLOBENZAPRINE, PREGABALIN, PREGABALIN, PREGABALIN, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, PREDNISONE, PREDNISONE, PREDNISONE, MONTELUKAST SODIUM, MONTELUKAST SODIUM, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE, BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE, BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE, DULOXETINE HYDROCHLORIDE, DULOXETINE, DULOXETINE HYDROCHLORIDE, DULOXETINE, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
271 | 25104132 |
CA |
72 | 1 |
Anxiety, Arteriosclerosis, Arteriosclerosis coronary artery, Asthma, Condition aggravated, Conjunctivitis allergic, Dust allergy, Eosinophilic granulomatosis with polyangiitis, Full blood count abnormal, Haemoptysis, Hypothyroidism, Hypoxia, Loss of personal independence in daily activities, Lung disorder, Mite allergy, Mycotic allergy, Neuritis, Neurological symptom, Nodule, Normochromic normocytic anaemia, Obstructive airways disorder, Pain in extremity, Productive cough, Pulmonary alveolar haemorrhage, Pulmonary embolism, Pulmonary fibrosis, Pulmonary vasculitis, Respiratory symptom, Skin exfoliation, Sleep disorder due to a general medical condition, Spirometry abnormal, Thrombosis, Wheezing, Dyspnoea, Therapeutic product effect incomplete, |
||||
FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, AMOXICILLIN, APIXABAN, BUDESONIDE, BUDESONIDE, CALCIUM CARBONATE, CICLESONIDE, CICLESONIDE, CICLESONIDE, DOXAZOSIN, DOXAZOSIN MESYLATE, DOXAZOSIN, DOXAZOSIN MESYLATE, DOXAZOSIN, DOXAZOSIN MESYLATE, DUTASTERIDE, DUTASTERIDE, DUTASTERIDE, DUTASTERIDE, APIXABAN, ERGOCALCIFEROL, ERGOCALCIFEROL, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, MAGNESIUM OXIDE, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN, CICLESONIDE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, ALBUTEROL SULFATE, ALBUTEROL, TIOTROPIUM BROMIDE, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, ERGOCALCIFEROL, ERGOCALCIFEROL, ERGOCALCIFEROL, DOXAZOSIN MESYLATE, ERGOCALCIFEROL, ROSUVASTATIN, ROSUVASTATIN CALCIUM, ALBUTEROL SULFATE, ALBUTEROL, |
||||
272 | 25104491 |
GB |
74 | 2 |
Asthma, Cough, |
||||
AMLODIPINE, AMLODIPINE, AMLODIPINE, AMLODIPINE, MONTELUKAST, MONTELUKAST, MONTELUKAST, MONTELUKAST, EZETIMIBE, EZETIMIBE, EZETIMIBE, EZETIMIBE, MOMETASONE, MOMETASONE, MOMETASONE, MOMETASONE, PREGABALIN, PREGABALIN, PREGABALIN, PREGABALIN, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
273 | 25104866 |
US |
2 | |
Asthma, Product dose omission issue, |
||||
MEPOLIZUMAB, |
||||
274 | 25105033 |
CA |
59 | 2 |
Asthma, Dyspnoea, Pneumonia, Sleep disorder due to a general medical condition, Wheezing, Loss of personal independence in daily activities, |
||||
CICLESONIDE, ALBUTEROL SULFATE, MEPOLIZUMAB, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, PREDNISONE, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE, |
||||
275 | 25105034 |
CA |
73 | 2 |
Arthritis, Asthma, Depression, Dyspnoea, Glaucoma, Sleep apnoea syndrome, |
||||
CICLESONIDE, TELMISARTAN, AMLODIPINE, GABAPENTIN, GLYCOPYRROLATE, PREDNISONE, ALBUTEROL SULFATE, CYANOCOBALAMIN, |
||||
276 | 25105143 |
US |
67 | 2 |
Rash, Injection site pain, Blister, Chest discomfort, Blood pressure increased, Asthma, |
||||
MONTELUKAST, DUPILUMAB, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
277 | 25105145 |
US |
||
Illness, Asthma, Influenza, Dyspnoea, Drug dose omission by device, Device delivery system issue, Product quality issue, Device mechanical issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, |
||||
278 | 25105154 |
CA |
64 | 2 |
Asthma, Cough, Acute respiratory failure, Dyspnoea, Loss of personal independence in daily activities, Malaise, Poor quality sleep, Respiratory tract infection, Tympanosclerosis, Wheezing, Drug abuse, Therapeutic product effect incomplete, |
||||
CICLESONIDE, ALBUTEROL SULFATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, ALBUTEROL SULFATE, MONTELUKAST SODIUM, OMALIZUMAB, MEPOLIZUMAB, OMALIZUMAB, TIOTROPIUM BROMIDE, ERGOCALCIFEROL, |
||||
279 | 25105157 |
CA |
59 | 1 |
Oesophageal carcinoma, Asthma, Decreased activity, Therapeutic product effect incomplete, Dyspnoea, Eosinophil count abnormal, Wheezing, |
||||
CICLESONIDE, ALBUTEROL SULFATE, TIOTROPIUM BROMIDE, AZITHROMYCIN DIHYDRATE, PREDNISONE, |
||||
280 | 25105158 |
CA |
79 | 1 |
Fall, Full blood count abnormal, Asthma, Respiration abnormal, Therapeutic product effect incomplete, |
||||
ACLIDINIUM BROMIDE, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, ALBUTEROL SULFATE, FLUTICASONE PROPIONATE AND SALMETEROL, FLUTICASONE PROPIONATE AND SALMETEROL, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, PREDNISONE, MONTELUKAST SODIUM, OXYGEN, 0XYGEN, |
||||
281 | 25105169 |
CA |
||
Hypoaesthesia, Exostosis, Malaise, Pemphigus, Fibromyalgia, Vomiting, Tachycardia, Abdominal discomfort, Fatigue, Bone erosion, Joint dislocation, Nausea, Osteoarthritis, Asthma, Pericarditis, Duodenal ulcer perforation, Hand deformity, Oedema peripheral, Condition aggravated, Psoriatic arthropathy, Lupus vulgaris, Systemic lupus erythematosus, Foot deformity, Swelling, Decreased appetite, Lupus-like syndrome, Pain, Diarrhoea, Crohn^s disease, C-reactive protein increased, Synovitis, Rheumatoid arthritis, Arthropathy, Joint swelling, Arthralgia, Anti-cyclic citrullinated peptide antibody positive, Joint stiffness, Swollen joint count increased, Mobility decreased, Musculoskeletal stiffness, Pain in extremity, Arthritis, Anti-cyclic citrullinated peptide antibody, Rheumatoid factor positive, Upper respiratory tract infection, Off label use, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, GOLIMUMAB, GOLIMUMAB, CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, MINOCYCLINE HYDROCHLORIDE, MINOCYCLINE HYDROCHLORIDE, MINOCYCLINE HYDROCHLORIDE, MINOCYCLINE HYDROCHLORIDE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, ADALIMUMAB, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, CALCIUM CARBONATE, DESOXIMETASONE, ERGOCALCIFEROL, DOXYCYCLINE, DOXYCYCLINE HYCLATE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, ERGOCALCIFEROL, METHYLPREDNISOLONE SODIUM SUCCINATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, LANSOPRAZOLE, PREDNISONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, MORPHINE SULFATE, MORPHINE SULFATE, ASCORBIC ACID, APREMILAST, APREMILAST, APREMILAST, APREMILAST, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, HYDROCORTISONE, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, PREDNISONE, PREDNISONE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, AZATHIOPRINE, USTEKINUMAB, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, LISINOPRIL, CAFFEINE CITRATE, CALCIUM GLUCONATE, LORAZEPAM, ACETAMINOPHEN AND CODEINE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, ACETAMINOPHEN AND CODEINE, BUPROPION HYDROCHLORIDE, BUPROPION, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, RAMIPRIL, RAMIPRIL, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, SULFASALAZINE, HYDROMORPHONE HYDROCHLORIDE, |
||||
282 | 25105894 |
US |
||
Cough, Headache, Gait inability, Fatigue, Asthma, Vomiting, |
||||
RISANKIZUMAB-RZAA, |
||||
283 | 25105910 |
CA |
69 | 2 |
Asthma, Eosinophil count decreased, Drug ineffective, Bacterial infection, Eosinophil count increased, Eosinophilic bronchitis, Myocardial infarction, Neutrophilia, Obstructive airways disorder, Polyp, Gastrooesophageal reflux disease, |
||||
RABEPRAZOLE SODIUM, RABEPRAZOLE, RISEDRONATE SODIUM, RAMIPRIL, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, CLOPIDOGREL, CLOPIDOGREL BISULFATE, HYDROCHLOROTHIAZIDE, PREDNISONE, ALBUTEROL SULFATE, ALBUTEROL, |
||||
284 | 25105939 |
CA |
||
Abdominal discomfort, Adjustment disorder with depressed mood, Alopecia, Amnesia, Anti-cyclic citrullinated peptide antibody, Anti-cyclic citrullinated peptide antibody positive, Anxiety, Arthralgia, Arthritis, Arthropathy, Asthma, Autoimmune disorder, Blister, Blood cholesterol increased, Bone erosion, C-reactive protein increased, Chest pain, Condition aggravated, Confusional state, Contusion, Decreased appetite, Deep vein thrombosis postoperative, Delirium, Depression, Diarrhoea, Disability, Discomfort, Dislocation of vertebra, Dizziness, Drug-induced liver injury, Duodenal ulcer perforation, Dyspepsia, Dyspnoea, Exostosis, Fatigue, Fibromyalgia, Foot deformity, Gait disturbance, Gait inability, General physical health deterioration, Glossodynia, Grip strength decreased, Hand deformity, Headache, Hepatic cirrhosis, Hepatic enzyme increased, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Impaired healing, Infusion related reaction, Injury, Insomnia, Irritable bowel syndrome, Joint dislocation, Joint range of motion decreased, Joint stiffness, Joint swelling, Liver function test increased, Liver injury, Loss of personal independence in daily activities, Lower limb fracture, Lupus vulgaris, Lupus-like syndrome, Memory impairment, Mobility decreased, Muscle injury, Muscular weakness, Musculoskeletal stiffness, Nausea, Oedema, Oedema peripheral, Osteoarthritis, Osteoporosis, Pain, Pain in extremity, Pemphigus, Pericarditis, Peripheral swelling, Pruritus, Psoriasis, Psoriatic arthropathy, Pulmonary fibrosis, Pyrexia, Rash, Red blood cell sedimentation rate increased, Rheumatic fever, Road traffic accident, Sciatica, Seronegative arthritis, Sleep disorder, Sleep disorder due to a general medical condition, Spondylitis, Stomatitis, Swelling, Swollen joint count increased, Synovitis, Systemic lupus erythematosus, Tachycardia, Type 2 diabetes mellitus, Urticaria, Visual impairment, Vomiting, Weight decreased, Weight increased, Wheezing, Wound, Walking aid user, Spinal fusion surgery, Hip arthroplasty, Crohn^s disease, Rheumatoid arthritis, Rheumatoid factor positive, Retinitis, Bronchitis, Laryngitis, Ear infection, Nasopharyngitis, Sinusitis, Folliculitis, Upper respiratory tract infection, Infection, Helicobacter infection, Pneumonia, Wound infection, Breast cancer stage III, Prescribed underdose, Prescribed overdose, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, APREMILAST, APREMILAST, APREMILAST, APREMILAST, APREMILAST, AZATHIOPRINE, CALCIUM CARBONATE, CALCIUM GLUCONATE, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CERTOLIZUMAB PEGOL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CHLORHEXIDINE ACETATE, CHLORHEXIDINE ACETATE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CLONIDINE HYDROCHLORIDE, CLONIDINE, HYDROCORTISONE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, ETANERCEPT, ETANERCEPT, VEDOLIZUMAB, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, GOLIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, HYDROCORTISONE SODIUM SUCCINATE, HYDROCORTISONE SODIUM SUCCINATE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, INFLIXIMAB, INFLIXIMAB, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, MESALAMINE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MORPHINE SULFATE, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, OXYCODONE, PREGABALIN, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, QUETIAPINE FUMARATE, QUETIAPINE, SODIUM FLUORIDE, SODIUM FLUORIDE F 18, SODIUM FLUORIDE F-18, TOOTHPASTE, SODIUM FLUORIDE F18, CLEAR MINT, GEL TOOTHPASTE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOFACITINIB, TOFACITINIB, TRAMADOL HYDROCHLORIDE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRICLOSAN, USTEKINUMAB, ERGOCALCIFEROL, ERGOCALCIFEROL, |
||||
285 | 25106157 |
CA |
65 | 2 |
Asthma, Chest pain, Cough, Drug hypersensitivity, Dyspnoea, Malaise, Nasal oedema, Oedema, Pain, Pneumonia, Respiratory tract infection, Wheezing, Vomiting, |
||||
OMALIZUMAB, OMALIZUMAB, RITUXIMAB, CLONAZEPAM, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, |
||||
286 | 25106481 |
US |
55 | 2 |
Back disorder, Asthma, |
||||
SOMATROPIN, SOMATROPIN, |
||||
287 | 25106538 |
CA |
64 | 2 |
Acute respiratory failure, Respiratory tract infection, Drug abuse, Asthma, Wheezing, Dyspnoea, Loss of personal independence in daily activities, Cough, Tympanosclerosis, Malaise, Poor quality sleep, Therapeutic product effect incomplete, |
||||
CICLESONIDE, ALBUTEROL SULFATE, MEPOLIZUMAB, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, ALBUTEROL SULFATE, MONTELUKAST SODIUM, OMALIZUMAB, TIOTROPIUM BROMIDE, ERGOCALCIFEROL, |
||||
288 | 25106575 |
DE |
||
Heavy menstrual bleeding, Pneumonitis, Deafness, Drug interaction, Depression, Epstein-Barr virus infection, Asthma, Pain in extremity, Arthralgia, Eructation, Endocrine disorder, Parosmia, Post-acute COVID-19 syndrome, Ear inflammation, Temperature intolerance, Withdrawal syndrome, Smoke sensitivity, Inflammation, Viral infection, Drug intolerance, Sensitivity to weather change, Premenstrual syndrome, Infection, Painful respiration, Hormone level abnormal, Nasal inflammation, Product dose omission in error, Drug ineffective, |
||||
FLUTICASONE PROPIONATE, ALBUTEROL SULFATE, ALBUTEROL, HYDROCORTISONE, |
||||
289 | 25106590 |
CA |
65 | 2 |
Drug hypersensitivity, Pneumonia, Wheezing, Asthma, Dyspnoea, Oedema, Vomiting, |
||||
RITUXIMAB, OMALIZUMAB, CLONAZEPAM, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN, MONTELUKAST, THEOPHYLLINE, CIPROFLOXACIN HYDROCHLORIDE, AMLODIPINE BESYLATE, RISEDRONATE SODIUM, ROSUVASTATIN CALCIUM, HYDROMORPHONE HYDROCHLORIDE, ROPIVACAINE HYDROCHLORIDE, ERGOCALCIFEROL, CALCIUM, TRAMADOL HYDROCHLORIDE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, PREDNISONE, |
||||
290 | 25106901 |
US |
||
Pneumonia, Influenza, Asthma, |
||||
MEPOLIZUMAB, |
||||
291 | 25106945 |
US |
68 | 2 |
Asthma, |
||||
292 | 25097330 |
US |
2 | |
Asthma, Rebound effect, Product dose omission issue, |
||||
DUPILUMAB, ERGOCALCIFEROL, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, TIOTROPIUM BROMIDE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, |
||||
293 | 25097536 |
CA |
65 | 2 |
Dyspnoea, Pneumonia, Wheezing, Vomiting, Asthma, Drug hypersensitivity, Oedema, |
||||
ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, AMLODIPINE, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, CLONAZEPAM, FOLIC ACID, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN, PREDNISONE, RISEDRONATE SODIUM, ROSUVASTATIN, AMINOPHYLLINE, OMALIZUMAB, RITUXIMAB, ROPIVACAINE HYDROCHLORIDE, MONTELUKAST SODIUM, |
||||
294 | 25097617 |
US |
62 | 2 |
Off label use, Asthma, |
||||
OMALIZUMAB, OMALIZUMAB, |
||||
295 | 25097750 |
CA |
65 | 2 |
Asthma, Drug hypersensitivity, Dyspnoea, Oedema, Pneumonia, Vomiting, Wheezing, |
||||
RITUXIMAB, OMALIZUMAB, |
||||
296 | 25097781 |
US |
55 | 2 |
Asthma, Drug ineffective, |
||||
DUPILUMAB, EPINEPHRINE, ADRENALINUM, ERGOCALCIFEROL, MONTELUKAST SODIUM, MONTELUKAST, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, OMALIZUMAB, |
||||
297 | 25097955 |
US |
56 | 2 |
Asthma, |
||||
ABATACEPT, |
||||
298 | 25097999 |
US |
64 | 2 |
Asthma, |
||||
DUPILUMAB, |
||||
299 | 25098056 |
US |
68 | 1 |
Asthma exercise induced, Asthma, |
||||
DUPILUMAB, |
||||
300 | 25098208 |
CA |
55 | |
Asthma, Full blood count abnormal, Bronchial hyperreactivity, Eosinophil count increased, Therapeutic product effect incomplete, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, MEPOLIZUMAB, MONTELUKAST SODIUM, ALBUTEROL SULFATE, TIOTROPIUM BROMIDE, PREDNISONE, ALBUTEROL SULFATE, |
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28